Hyloris Pharmaceuticals Eulerpool Vijesti

Hyloris Pharmaceuticals Eulerpool News

Hyloris Pharmaceuticals Aktie News

Hyloris Pharmaceuticals prate mnogi novinari i investitori širom svijeta. Najnovije Hyloris Pharmaceuticals vijesti prikupljamo ovdje.

• 14. ožujka ·

  Yahoo
  Hyloris Reports Full Year Results for 2023 & Provides Business Outlook
• 14. ožujka ·

  Yahoo
  Communication at the request of the FSMA on the transactions with Qliniq
• 8. ožujka ·

  Yahoo
  Hyloris to Report 2023 Full-Year Results on 14 March 2024
• 27. veljače ·

  Yahoo
  Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada
• 14. veljače ·

  Yahoo
  Hyloris Enrolls First Patient in Phase 3 Clinical Trial for its Proprietary Mouth Rinse to Control Incidences of Bleeding Related to Dental Procedures
• 30. siječnja ·

  Yahoo
  Hyloris and Purna Female Healthcare Announce Positive Results from Phase 2 Trial in Patients with Acute Vulvovaginal Candidiasis (VVC)
• 18. siječnja ·

  Yahoo
  Hyloris Broadens Pipeline with new Product Candidate for Vulvar Lichen Sclerosus (VLS)
• 16. siječnja ·

  Yahoo
  Orphan Drug Designation Granted to PTX-252 by U.S. FDA for the Treatment of Acute Myeloid Leukaemia (AML)
• 16. siječnja ·

  Yahoo
  Pleco Therapeutics receives FDA Orphan Drug Designation
• 26. prosinca ·

  Yahoo
  Hyloris Announces Positive Clinical Study Results for Valacyclovir Oral Suspension (HY-029)